{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:32:38Z","timestamp":1780410758132,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1136\/ard.2003.019695","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T00:38:39Z","timestamp":1083631119000},"page":"85-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout"],"prefix":"10.1016","volume":"64","author":[{"given":"F","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"Tinahones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Collantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Garc\u00eda-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"Soriguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.019695_bib1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7326\/0003-4819-34-6-1421","article-title":"Serum uric acid in relation to age and physique in health and coronary heart disease","volume":"34","author":"Gertler","year":"1951","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.019695_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0895-4356(96)00034-0","article-title":"High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers?","volume":"49","author":"Iribarren","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/ard.2003.019695_bib3","first-page":"159","article-title":"Association of elevated uric acid with coronary heart disease in diabetes mellitus","volume":"19","author":"Rathmann","year":"1993","journal-title":"Diabete Metab"},{"key":"10.1136\/ard.2003.019695_bib4","first-page":"25","article-title":"Hyperuricemia and insulin resistance","volume":"78","author":"Vuorinen-Markkola","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.2003.019695_bib5","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini","year":"1991","journal-title":"JAMA"},{"key":"10.1136\/ard.2003.019695_bib6","first-page":"E1","article-title":"Effect of insulin on uric acid excretion in humans","volume":"268","author":"Galvan","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1136\/ard.2003.019695_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199602083340607","article-title":"Hypertension and associated metabolic abnormalities the role of insulin resistance and the sympathoadrenal system","volume":"334","author":"Reaven","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.019695_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF00296994","article-title":"Elevated serum uric acid a facet of hyperinsulinemia","volume":"30","author":"Modan","year":"1987","journal-title":"Diabetologia"},{"key":"10.1136\/ard.2003.019695_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/oxfordjournals.aje.a115593","article-title":"Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other chemistries","volume":"131","author":"Selby","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.2003.019695_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1993.tb00700.x","article-title":"Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia","volume":"234","author":"Zavaroni","year":"1993","journal-title":"J Intern Med"},{"key":"10.1136\/ard.2003.019695_bib11","first-page":"1043","article-title":"Gout. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds","author":"Wyngaarden","year":"1983","journal-title":"The metabolic basis of inherited disease"},{"key":"10.1136\/ard.2003.019695_bib12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/oxfordjournals.aje.a115424","article-title":"Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin","volume":"130","author":"Folsom","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1136\/ard.2003.019695_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4615-5381-6_12","article-title":"Lipoproteins in patients with isolated hyperuricemia","volume":"431","author":"Tinahones","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1136\/ard.2003.019695_bib14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/34.10.920","article-title":"Increased VLDL levels and diminished renal excretion of uric acid in hyperuricaemic-hypertriglyceridaemic patients","volume":"34","author":"Tinahones","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.019695_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0022-2275(20)31678-3","article-title":"New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia","volume":"42","author":"Groenendijk","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1136\/ard.2003.019695_bib16","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.99.14.1872","article-title":"ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests","volume":"99","author":"Waterworth","year":"1999","journal-title":"Circulation"},{"key":"10.1136\/ard.2003.019695_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0140-6736(85)90350-2","article-title":"Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction","volume":"ii","author":"Ferns","year":"1985","journal-title":"Lancet"},{"key":"10.1136\/ard.2003.019695_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0021-9150(91)90234-T","article-title":"Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III and A-IV gene locus: relationships with lipids, apolipoproteins and premature coronary artery disease","volume":"87","author":"Ordov\u00e1s","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1136\/ard.2003.019695_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ajcn\/66.1.97","article-title":"Influence of the SstI polymorphic site at the apolipoprotein C-III gene on plasma LDL cholesterol response to monounsaturated dietary fat","volume":"66","author":"L\u00f3pez","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"10.1136\/ard.2003.019695_bib20","first-page":"67","article-title":"The A\/G polymorphism in the \u221278 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency","volume":"1398","author":"Danek","year":"1998","journal-title":"Biochem Biophys Acta"},{"key":"10.1136\/ard.2003.019695_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gepi.1370100204","article-title":"Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo A-I levels in boys and girls","volume":"10","author":"Xu","year":"1993","journal-title":"Genet Epidemiol"},{"key":"10.1136\/ard.2003.019695_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)39972-7","article-title":"Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels","volume":"35","author":"Barre","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1136\/ard.2003.019695_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1399-0004.1993.tb03906.x","article-title":"Adenine for guanine substitution. 78 base pairs to the apolipoprotein (apo) A-I gene: relation with high density lipoprotein cholesterol and apo A-I concentrations","volume":"44","author":"Civeira","year":"1993","journal-title":"Clin Genet"},{"key":"10.1136\/ard.2003.019695_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-8227(02)00002-5","article-title":"Diabetes Group of the Andalusian Society of Endocrinology and Nutrition. Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain","volume":"56","author":"Soriguer-Escofet","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1136\/ard.2003.019695_bib25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1136\/ard.2003.019695_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2144\/99272bm06","article-title":"Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis","volume":"27","author":"Queipo-Ortuno","year":"1999","journal-title":"Biotechniques"},{"key":"10.1136\/ard.2003.019695_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00222727","article-title":"Characterization of genetic markers in the 5\u2032 flanking region of the apo A1 gene","volume":"91","author":"Shoulders","year":"1993","journal-title":"Hum Genet"},{"key":"10.1136\/ard.2003.019695_bib28","first-page":"233","article-title":"G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations","volume":"7","author":"Jeenah","year":"1990","journal-title":"Mol Biol Med"},{"key":"10.1136\/ard.2003.019695_bib29","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.90.10.4562","article-title":"An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3_UTR polymorphisms","volume":"90","author":"Dammerman","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2003.019695_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1047-2797(97)00204-4","article-title":"Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults","volume":"8","author":"Rathmann","year":"1998","journal-title":"Ann Epidemiol"},{"key":"10.1136\/ard.2003.019695_bib31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.019695_bib32","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/34.10.920","article-title":"Increased VLDL levels and diminished renal excretion of uric acid in hyperuricaemic-hypertriglyceridaemic patients","volume":"34","author":"Tinahones","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.019695_bib33","first-page":"1188","article-title":"Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients","volume":"82","author":"Tinahones","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.2003.019695_bib34","first-page":"468","article-title":"The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates","volume":"42","author":"Cardona","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2003.019695_bib35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-2275(20)37642-2","article-title":"Apolipoprotein A-I\/C-III\/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III","volume":"37","author":"Dallinga-Thie","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1136\/ard.2003.019695_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2796.1997.122139000.x","article-title":"Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults","volume":"241","author":"Meng","year":"1997","journal-title":"J Intern Med"},{"key":"10.1136\/ard.2003.019695_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00208984","article-title":"C to T and\/or G to A transitions are responsible for loss of a MspI restriction site at the 5\u2032-end of the human apolipoprotein AI gene","volume":"95","author":"Wang","year":"1995","journal-title":"Hum Genet"},{"key":"10.1136\/ard.2003.019695_bib38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1172\/JCI118802","article-title":"Polymorphisms at the 5\u2032-end of the apolipoprotein AI gene and severity of coronary artery disease","volume":"98","author":"Wang","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2003.019695_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D","article-title":"New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels","volume":"13","author":"Wang","year":"1996","journal-title":"Genet Epidemiol"},{"key":"10.1136\/ard.2003.019695_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1399-0004.1985.tb00403.x","article-title":"A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals","volume":"28","author":"Kessling","year":"1985","journal-title":"Clin Genet"},{"key":"10.1136\/ard.2003.019695_bib41","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI119260","article-title":"Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. identification of different susceptibility haplotypes","volume":"99","author":"Dallinga-Thie","year":"1997","journal-title":"J Clin Invest"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672443183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672443183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.019695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:23:19Z","timestamp":1737264199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672443183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S000349672443183X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.019695","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.019695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}